Locations:
SearchAdvertisement
Cleveland Clinic Cognitive Battery identifies at-risk patients during Medicare annual visits
Pairing machine learning with multi-omics revealed potential therapeutic targets
Awards fund research on oxidative targets, immunometabolism, spatial navigation testing and more
Recognizing this association aids risk assessment before starting novel immunotherapies
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
GFAP elevation may signal increased risk of progressive regional atrophy, cognitive decline
Study suggests sex-specific pathways show potential for sex-specific therapeutic approaches
For some older adults, a rural setting in late life may be protective
Patients benefit when doctors disclose with care
Criteria-based diagnosis of traumatic encephalopathy syndrome predicts changes in brain volumes and cognition
Plasma proteome analysis aimed at identifying candidate blood-based biomarkers in women
Advertisement
Advertisement